ArticlePloS one2026
Assessment of miRNAs as transcriptional regulators in respiratory syncytial virus infection through computational analysis and molecular docking studies.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Investigating the Role of microRNA in Host-Influenza A and Other Respiratory RNA Virus Interactions.Pathogens (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Globally, RSV is a major contributor to severe lower respiratory tract infections among children. Despite the significant medical concern posed by RSV, efforts to develop effective vaccines and antiviral drugs have largely fallen short, with the exception of immune prophylaxis available only for specific high-risk infants. We employed a suite of computational tools to investigate the role of microRNAs in the host's response to RSV infection. miRanda and RNAHybrid were instrumental in predicting microRNA-mRNA binding sites. For a deeper structural analysis, MC-Fold and MC-Sym were used to predict the 3D structures of both the miRNAs and their target mRNAs. The interactions between these molecules were then studied through RNA-RNA docking, with the resulting poses evaluated based on binding affinities and interaction profiles. This analysis focused on twelve selected miRNAs and their binding to specific sites on RSV mRNA. Finally, molecular dynamics (MD) simulations were conducted to evaluate the stability of the docked complexes. Taken together, these results suggest that two miRNAs, hsa_miR-2278 and hsa_miR-6732-3p, could potentially regulate the transcriptional activity during RSV infection and may warrant consideration as therapeutic agents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.